Drugs and Devices

FDA approves first combination tablet to treat type 2 diabetes and high cholesterol

The U.S. Food and Drug Administration has approved Juvisync (sitagliptin and simvastatin), the first combination drug to treat type 2 diabetes and high cholesterol in one tablet. Read more.


Related Articles:

Leave a Reply

Your email address will not be published. Required fields are marked *

 

Shares